Meribank Biotech Co (ROCO:4724) Net Change in Cash : NT$314.3 Mil (TTM As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Meribank Biotech Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Meribank Biotech Co's Net Change in Cash for the six months ended in Dec. 2023 was NT$337.9 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was NT$314.3 Mil.

Meribank Biotech Co Net Change in Cash Historical Data

The historical data trend for Meribank Biotech Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meribank Biotech Co Net Change in Cash Chart

Meribank Biotech Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

-6.06

-3.77

140.76

-106.99

314.30

Meribank Biotech Co Semi-Annual Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Change in Cash	Get a 7-Day Free Trial							-92.50	-63.83	-43.16	-23.60	337.90

Meribank Biotech Co Net Change in Cash Calculation

Meribank Biotech Co's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-29.699	+	48.152	+	295.846	+	0
	=	314.3

Meribank Biotech Co's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -17.943 + 48.597 + 307.242 + 0

= 337.9

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$314.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Meribank Biotech Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Meribank Biotech Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Meribank Biotech Co (ROCO:4724) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Meribank Biotech Co Ltd (ROCO:4724) » Definitions » Net Change in Cash

Comparable Companies

ROCO:6564 ROCO:6580 TPE:1733 ROCO:7427 ROCO:4194 ROCO:6879 ROCO:4130 ROCO:6846 TPE:3164 ROCO:4168 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX

Traded in Other Exchanges

N/A

Address

Sector 1, Neihu Road, 1st Floor, No.68, Neihu District, Taipei, TWN, 11493

Website

http://www.meribank.com.tw

Meribank Biotech Co Ltd is engaged in Research and development and sales of new cell drugs and also Umbilical cord blood, placenta and umbilical cord mesenchymal stem cells processing, testing and cryopreservation.

Meribank Biotech Co (ROCO:4724) Headlines

No Headlines